Shai Novik, Executive Chairman of the Board at Enlivex Therapeutics, Ltd. ENLV, was a guest speaker at Benzinga’s All Access on June 17th, 2022.
Enlivex Therapeutics is a clinical stage, macrophage reprogramming immunotherapy company developing Allocetra - an off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.
Watch full interview here
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.